Novo Nordisk (NVO)
(Delayed Data from NYSE)
$131.54 USD
+1.55 (1.19%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $131.58 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $0.76 | -3.76% |
Earnings Summary
For their last quarter, Novo Nordisk (NVO) reported earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.77 per share. This reflects a positive earnings surprise of 7.79%. Look out for NVO's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of $0.76 per share, reflecting a year-over-year increase of 20.63%.
Earnings History
Price & Consensus
Zacks News for NVO
Novo Nordisk, Lilly Slide on Roche's Obesity Drug Study Data
NVO: What are Zacks experts saying now?
Zacks Private Portfolio Services